Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 199

1.

Exenatide once weekly versus daily basal insulin as add-on treatment to metformin with or without a sulfonylurea: a retrospective pooled analysis in patients with poor glycemic control.

Grimm M, Li Y, Brunell SC, Blase E.

Postgrad Med. 2013 Sep;125(5):101-8. doi: 10.3810/pgm.2013.09.2704.

PMID:
24113668
[PubMed - indexed for MEDLINE]
2.

Once-weekly exenatide versus once- or twice-daily insulin detemir: randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas.

Davies M, Heller S, Sreenan S, Sapin H, Adetunji O, Tahbaz A, Vora J.

Diabetes Care. 2013 May;36(5):1368-76. doi: 10.2337/dc12-1333. Epub 2012 Dec 28.

PMID:
23275363
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus: an integrated analysis of the DURATION trials.

Grimm M, Han J, Weaver C, Griffin P, Schulteis CT, Dong H, Malloy J.

Postgrad Med. 2013 May;125(3):47-57. doi: 10.3810/pgm.2013.05.2660.

PMID:
23748506
[PubMed - indexed for MEDLINE]
4.

Efficacy and tolerability of exenatide once weekly versus sitagliptin in patients with type 2 diabetes mellitus: a retrospective analysis of pooled clinical trial data.

Malloy J, Meloni A, Han J.

Postgrad Med. 2013 May;125(3):58-67. doi: 10.3810/pgm.2013.05.2661.

PMID:
23748507
[PubMed - indexed for MEDLINE]
5.

Safety and efficacy of once-weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes over 84 weeks.

Diamant M, Van Gaal L, Stranks S, Guerci B, MacConell L, Haber H, Scism-Bacon J, Trautmann M.

Diabetes Care. 2012 Apr;35(4):683-9. doi: 10.2337/dc11-1233. Epub 2012 Feb 22.

PMID:
22357185
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals.

Meloni AR, DeYoung MB, Han J, Best JH, Grimm M.

Cardiovasc Diabetol. 2013 Mar 23;12:48. doi: 10.1186/1475-2840-12-48.

PMID:
23522121
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Exenatide once weekly for the treatment of type 2 diabetes mellitus: clinical results in subgroups of patients using different concomitant medications.

Pencek R, Brunell SC, Li Y, Hoogwerf BJ, Malone J.

Postgrad Med. 2012 Jul;124(4):33-40. doi: 10.3810/pgm.2012.07.2568.

PMID:
22913892
[PubMed - indexed for MEDLINE]
8.
9.

Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea.

Bergenstal R, Lewin A, Bailey T, Chang D, Gylvin T, Roberts V; NovoLog Mix-vs.-Exenatide Study Group.

Curr Med Res Opin. 2009 Jan;25(1):65-75. doi: 10.1185/03007990802597951 .

PMID:
19210140
[PubMed - indexed for MEDLINE]
10.
11.

Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study.

Russell-Jones D, Cuddihy RM, Hanefeld M, Kumar A, González JG, Chan M, Wolka AM, Boardman MK; DURATION-4 Study Group.

Diabetes Care. 2012 Feb;35(2):252-8. doi: 10.2337/dc11-1107. Epub 2011 Dec 30.

PMID:
22210563
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.

Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG; GWAA Study Group.

Ann Intern Med. 2005 Oct 18;143(8):559-69.

PMID:
16230722
[PubMed - indexed for MEDLINE]
13.

Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.

Buse JB, Bergenstal RM, Glass LC, Heilmann CR, Lewis MS, Kwan AY, Hoogwerf BJ, Rosenstock J.

Ann Intern Med. 2011 Jan 18;154(2):103-12. doi: 10.7326/0003-4819-154-2-201101180-00300. Epub 2010 Dec 6.

PMID:
21138825
[PubMed - indexed for MEDLINE]
14.

Comparative efficacy of exenatide versus insulin glargine on glycemic control in type 2 diabetes mellitus patients inadequately treated with metformin monotherapy.

Karagianni P, Polyzos SA, Kartali N, Zografou I, Sambanis C.

Adv Med Sci. 2013;58(1):38-43. doi: 10.2478/v10039-012-0078-7.

PMID:
23640946
[PubMed - indexed for MEDLINE]
15.

Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes.

Meneghini L, Kesavadev J, Demissie M, Nazeri A, Hollander P.

Diabetes Obes Metab. 2013 Aug;15(8):729-36. doi: 10.1111/dom.12083. Epub 2013 Mar 13.

PMID:
23421331
[PubMed - indexed for MEDLINE]
16.
17.

The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ≥30 kg/m(2) in Spain.

Fonseca T, Clegg J, Caputo G, Norrbacka K, Dilla T, Alvarez M.

J Med Econ. 2013 Jul;16(7):926-38. doi: 10.3111/13696998.2013.803110. Epub 2013 May 31.

PMID:
23659201
[PubMed - indexed for MEDLINE]
18.

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. doi: 10.1016/j.clinthera.2008.08.006. Erratum in: Clin Ther. 2008 Oct;30(10):1937.

PMID:
18803987
[PubMed - indexed for MEDLINE]
19.

Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study.

Davies MJ, Donnelly R, Barnett AH, Jones S, Nicolay C, Kilcoyne A.

Diabetes Obes Metab. 2009 Dec;11(12):1153-62. doi: 10.1111/j.1463-1326.2009.01154.x.

PMID:
19930005
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Safety and efficacy of twice-daily exenatide in Taiwanese patients with inadequately controlled type 2 diabetes mellitus.

Lu CH, Wu TJ, Shih KC, Ni E, Reed V, Yu M, Sheu WH, Chuang LM.

J Formos Med Assoc. 2013 Mar;112(3):144-50. doi: 10.1016/j.jfma.2012.02.027. Epub 2012 Jun 12.

PMID:
23473527
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk